CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus

Nur Rochmah,1 Muhammad Faizi,1 Suhasta Nova,1 Retno Asih Setyoningrum,1 Sukmawati Basuki,2 Anang Endaryanto1 1Faculty of Medicine, Department of Child Health, Dr. Soetomo General Hospital, Universitas Airlangga, Surabaya, East Java, Indonesia; 2Institute of Tropical Disease, Universitas Airlangga, S...

Full description

Bibliographic Details
Main Authors: Rochmah N, Faizi M, Nova S, Setyoningrum RA, Basuki S, Endaryanto A
Format: Article
Language:English
Published: Dove Medical Press 2022-04-01
Series:The Application of Clinical Genetics
Subjects:
Online Access:https://www.dovepress.com/ctla-4-ct-60-ag-and-ctla-4-1822-ct-gene-polymorphisms-in-indonesians-w-peer-reviewed-fulltext-article-TACG
_version_ 1818011558429589504
author Rochmah N
Faizi M
Nova S
Setyoningrum RA
Basuki S
Endaryanto A
author_facet Rochmah N
Faizi M
Nova S
Setyoningrum RA
Basuki S
Endaryanto A
author_sort Rochmah N
collection DOAJ
description Nur Rochmah,1 Muhammad Faizi,1 Suhasta Nova,1 Retno Asih Setyoningrum,1 Sukmawati Basuki,2 Anang Endaryanto1 1Faculty of Medicine, Department of Child Health, Dr. Soetomo General Hospital, Universitas Airlangga, Surabaya, East Java, Indonesia; 2Institute of Tropical Disease, Universitas Airlangga, Surabaya, East Java, IndonesiaCorrespondence: Nur Rochmah, Faculty of Medicine, Department of Child Health, Dr. Soetomo General Hospital, Universitas Airlangga, Mayjend Prof. Dr. Moestopo No. 6-8, Surabaya, East Java, 60286, Indonesia, Tel +6281703501118, Email nur-r@fk.unair.ac.idIntroduction: CTLA-4 gene polymorphism plays an important role in children with type 1 diabetes mellitus (T1DM). However, data on this subject vary among different races and ethnics.Purpose: To analyze CTLA-4 CT-60 A/G and CTLA-4 1822 C/T gene polymorphism among children with T1DM compared to control.Patients and Methods: The CTLA-4 CT-60 A/G and CTLA-4 1822 C/T gene polymorphism in children with T1DM using polymerase chain reaction-restriction fragment length polymorphism in 25 T1DM and 25 controls. The inclusion criteria were patients regularly controlled at the Pediatric Endocrine Outpatient Clinic of Dr. Soetomo Hospital, aged 4– 18 years and willing to join this study and the exclusion criteria were T1DM patients hospitalized in the pediatric intensive care unit. In the control group, the inclusion criteria were healthy children, aged 4– 18 years and willing to join this study. The exclusion criteria included children with ongoing infection, history of other autoimmune diseases, allergies, or malignancy.Results: The mean age was 12.48 years old, and the mean of T1DM onset was 9.28 years old. The CTLA-4 1822 T allele observed in 62% T1DM and 56% in control (p = 0.388, OR = 0.78, 95% CI = 0.44– 1.37) and CTLA-4 CT-60 G allele observed in 52% T1DM and 58% in control (p = 0.393, OR = 1.27, 95% CI = 0.73– 2.22). The C/T genotypes was significantly higher in control group (p = 0.045, OR = 3.27, 95% CI = 1.00– 10.62). The A/G genotypes was commonly found in control group (p = 0.765, OR = 1.20, 95% CI = 0.37– 3.86). The Javanese was the dominant ethnic group in our study.Conclusion: The frequency of CTLA-4 CT-60 A/G polymorphism almost equivalent in T1DM and control group. However, CTLA-4 1822 C/T polymorphism was more prevalent in the control group; thus, this genotype may have a protective effect against T1DM.Keywords: type 1 diabetes mellitus, CTLA-4
first_indexed 2024-04-14T06:09:17Z
format Article
id doaj.art-436c8f291131462bb354039f8d12fadd
institution Directory Open Access Journal
issn 1178-704X
language English
last_indexed 2024-04-14T06:09:17Z
publishDate 2022-04-01
publisher Dove Medical Press
record_format Article
series The Application of Clinical Genetics
spelling doaj.art-436c8f291131462bb354039f8d12fadd2022-12-22T02:08:24ZengDove Medical PressThe Application of Clinical Genetics1178-704X2022-04-01Volume 15192574899CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes MellitusRochmah NFaizi MNova SSetyoningrum RABasuki SEndaryanto ANur Rochmah,1 Muhammad Faizi,1 Suhasta Nova,1 Retno Asih Setyoningrum,1 Sukmawati Basuki,2 Anang Endaryanto1 1Faculty of Medicine, Department of Child Health, Dr. Soetomo General Hospital, Universitas Airlangga, Surabaya, East Java, Indonesia; 2Institute of Tropical Disease, Universitas Airlangga, Surabaya, East Java, IndonesiaCorrespondence: Nur Rochmah, Faculty of Medicine, Department of Child Health, Dr. Soetomo General Hospital, Universitas Airlangga, Mayjend Prof. Dr. Moestopo No. 6-8, Surabaya, East Java, 60286, Indonesia, Tel +6281703501118, Email nur-r@fk.unair.ac.idIntroduction: CTLA-4 gene polymorphism plays an important role in children with type 1 diabetes mellitus (T1DM). However, data on this subject vary among different races and ethnics.Purpose: To analyze CTLA-4 CT-60 A/G and CTLA-4 1822 C/T gene polymorphism among children with T1DM compared to control.Patients and Methods: The CTLA-4 CT-60 A/G and CTLA-4 1822 C/T gene polymorphism in children with T1DM using polymerase chain reaction-restriction fragment length polymorphism in 25 T1DM and 25 controls. The inclusion criteria were patients regularly controlled at the Pediatric Endocrine Outpatient Clinic of Dr. Soetomo Hospital, aged 4– 18 years and willing to join this study and the exclusion criteria were T1DM patients hospitalized in the pediatric intensive care unit. In the control group, the inclusion criteria were healthy children, aged 4– 18 years and willing to join this study. The exclusion criteria included children with ongoing infection, history of other autoimmune diseases, allergies, or malignancy.Results: The mean age was 12.48 years old, and the mean of T1DM onset was 9.28 years old. The CTLA-4 1822 T allele observed in 62% T1DM and 56% in control (p = 0.388, OR = 0.78, 95% CI = 0.44– 1.37) and CTLA-4 CT-60 G allele observed in 52% T1DM and 58% in control (p = 0.393, OR = 1.27, 95% CI = 0.73– 2.22). The C/T genotypes was significantly higher in control group (p = 0.045, OR = 3.27, 95% CI = 1.00– 10.62). The A/G genotypes was commonly found in control group (p = 0.765, OR = 1.20, 95% CI = 0.37– 3.86). The Javanese was the dominant ethnic group in our study.Conclusion: The frequency of CTLA-4 CT-60 A/G polymorphism almost equivalent in T1DM and control group. However, CTLA-4 1822 C/T polymorphism was more prevalent in the control group; thus, this genotype may have a protective effect against T1DM.Keywords: type 1 diabetes mellitus, CTLA-4https://www.dovepress.com/ctla-4-ct-60-ag-and-ctla-4-1822-ct-gene-polymorphisms-in-indonesians-w-peer-reviewed-fulltext-article-TACGtype 1 diabetes mellitusctla-4
spellingShingle Rochmah N
Faizi M
Nova S
Setyoningrum RA
Basuki S
Endaryanto A
CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
The Application of Clinical Genetics
type 1 diabetes mellitus
ctla-4
title CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
title_full CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
title_fullStr CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
title_full_unstemmed CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
title_short CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
title_sort ctla 4 ct 60 a g and ctla 4 1822 c t gene polymorphisms in indonesians with type 1 diabetes mellitus
topic type 1 diabetes mellitus
ctla-4
url https://www.dovepress.com/ctla-4-ct-60-ag-and-ctla-4-1822-ct-gene-polymorphisms-in-indonesians-w-peer-reviewed-fulltext-article-TACG
work_keys_str_mv AT rochmahn ctla4ct60agandctla41822ctgenepolymorphismsinindonesianswithtype1diabetesmellitus
AT faizim ctla4ct60agandctla41822ctgenepolymorphismsinindonesianswithtype1diabetesmellitus
AT novas ctla4ct60agandctla41822ctgenepolymorphismsinindonesianswithtype1diabetesmellitus
AT setyoningrumra ctla4ct60agandctla41822ctgenepolymorphismsinindonesianswithtype1diabetesmellitus
AT basukis ctla4ct60agandctla41822ctgenepolymorphismsinindonesianswithtype1diabetesmellitus
AT endaryantoa ctla4ct60agandctla41822ctgenepolymorphismsinindonesianswithtype1diabetesmellitus